Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the firm’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the sale, the insider now directly owns […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]
Castle Biosciences fortifies esophageal cancer awareness efforts fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of Castle Biosciences stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.45, for a total value of $196,310.40. Following the transaction, the director now owns 22,782 shares in the company, […]
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March.